## Abstract This study examined the frequency of loss of imprinting (LOI) and expression of the insulinβlike growth factor 2 (__IGF2__) gene, and their relationship to selected clinical and pathological factors, in a well defined series of 90 Chinese patients with gastric cancer (GC) and 90 matched
Relaxation of insulin-like growth factor 2 gene imprinting in esophageal cancer
β Scribed by Masaki Mori; Hiroshi Inoue; Takeshi Shiraishi; Koshi Mimori; Kenji Shibuta; Hideaki Nakashima; Kenichi Mafune; Youichi Tanaka; Hiroaki Ueo; Graham F. Barnard; Keizo Sugimachi; Tsuyoshi Akiyoshi
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 566 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Paternal allele-specific expression is identified for the insulinlike growth factor 2 (IGFZ) gene. Relaxation or loss of IGFZ imprinting, however, has been reported in several neoplasms.
We studied the expression of IGFZ mRNA in 35 s q w m w s cancers of the esophagus and searched for the presence or absence of relaxation of IGFZ imprinting. In 28 (80%) cases, IGFZ mRNA was overexpressed in the tumor tissues 0 compared to the normal tissues (N). The patients whose tumor invaded the adventitia showed a higher T/N ratio than those whose tumor was restricted to the musculi propria layer. Heterozygos*ty was determined by using the Apa I polymorphism in exon 9. Thirteen of 35 cases showed heterozygosity. In these 13 cases, a similar analysis was performed on cDNA obtained by reverse transcriptase-polymerase chain reaction. Consequently, 7 cases disclosed relaxation of IGFZ imprinting in the tumor tissue. The cases of esophageal cancer with relaxation of IGFZ imprinting showed a higher T/N ratio and deeper invasion than those without relaxation. The results suggest that overexpression of IGFZ mRNA plays an important role in esophageal cancer and, in certain cases, is associated with relaxation of IGFZ imprinting.
π SIMILAR VOLUMES
Insulin-like growth factor 2 (IGF2) gene imprinting has been demonstrated to be promoter-specific, in that expression from the P1 promoter is biallelic whereas that from the P2-P4 promoters is monoallelic. In the present study, in order to investigate IGF2 gene imprinting status at the cellular leve
## Abstract Loss of imprinting (LOI), the biallelic expression of an imprinting gene, of insulinβlike growth factor 2 (__IGF2__) has been reported to be associated with colorectal carcinogenesis because of its high prevalence in normal colorectal mucosa as well as cancerous tissue in patients with
Insulin-like growth factor II (IGF-II) plays significant roles in the growth and development of mammals through the regulation of mitogenesis and cell survival. Previously, IGF-II mRNA transcripts within the CNS were detected in the choroid plexus and leptomeninges (DeChiara et al., 1991). The objec
## Abstract The objective of this exploratory study was to evaluate the role of the insulinβlike growth factor I receptor (IGFβIR) in esophageal adenocarcinoma (EADC). Using quantitative PCR, we studied IGFβIR mRNA expression in 52 wellβcharacterized surgically resected EADC and matched histologica
## Background: Loss of imprinting (loi) of insulin-like growth factor-2 (igf-2) has been implicated in the pathogenesis of certain human cancers and tumor-predisposing overgrowth disorders, such as beckwith-wiedemann syndrome. in a previous study, the authors revealed that certain patients with chi